This page shows the latest Dementia Discovery Fund news and features for those working in and with pharma, biotech and healthcare.
The Dementia Discovery Fund (DDF) confirmed yesterday that it had raised £250m ($350m), boosted by a $60m investment from US non-profit organisation AARP, which aims to help older people live ... The fundraising far exceeded its initial target of $200m (
A new UK government-backed investment vehicle to provide long-term capital for British businesses has been launched, with a fund backing dementia drug developers among the first to benefit. ... The Dementia Discovery Fund is one of two VCs given funding
It will also set up a dedicated venture capital fund to invest in other companies carrying out neuroscience R&D and “support continued efforts to advance the field”. ... Pfizer is already one of the founder members of the cross-company Dementia
Fund aims to back 40 projects over its 15-year term. Thanks to a £15m pledge from Neil Woodford's investment group, the public-private Dementia Discovery Fund (DDF) has now ... therapies. The DDF's chief scientific officer - former Takeda drug discovery
Pharma giants collaborate with government to find new treatments. GlaxoSmithKline, Johnson &Johnson and Pfizer have signed up to support a new UK government dementia discovery fund. ... The fund will work with universities, academic institutes and the
Similar partnerships have been launched in recent years for conditions, including dementia and Parkinson's disease - both areas of significant unmet medical need. ... Earlier this year, Lilly, Pfizer, GlaxoSmithKline, Biogen Idec and Johnson &Johnson
More from news
Approximately 1 fully matching, plus 7 partially matching documents found.
In the meantime, she is challenging not just the accepted ways of conducting drug discovery, but also some of the male behaviour that can mar the working environment. ... the UK’s new Dementia Discovery Fund (DDF) and serves on the DDF Investment
This year, through J&J Innovation, we will invest $10m into the UK government-led Global Dementia Discovery Fund, supporting innovative research into the area. ... This was set up in 2013 to identify innovative solutions for dementia care.
This month saw GSK invest $25m, J&J $10m and the UK Government $22m into the Dementia Discovery fund, a joint initiative also including Lilly, Biogen and Pfizer to research treatments
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
To help address a lack of investment in novel dementia science a new £100M Dementia Discovery Fund ( ) was launched towards the end of last year. ... Managed by SV Life Sciences the fund is focused primarily on Phase I and II research and aims to help
More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....